Suárez-Ortega S, Puente-Fernández A, Santana-Baez S, Godoy-Díaz D, Serrano-Fuentes M, Sanz-Peláez O

Language: Spanish
References: 27
Page: 532-535
PDF size: 102.50 Kb.

ABSTRACT

Fatigue, anorexia and involuntary weight loss have been included under the term of constitutional syndrome.
These manifestations accompany many diseases in which the diagnosis is made by specifi c symptoms and signs. However, these events are generally the main reason for consultation and the patient does not report other specifi c data. This forces us to rigorously investigate the possible causes of the disorder. Usually, three manifestations coexist: asthenia, anorexia and weight loss, but sometimes the patient has only one or two of them. The causes of constitutional symptoms are varied and can be divided into three groups: psychiatric diseases, neoplasms and non-neoplastic diseases. The etiological identifi cation is usually done with a simple protocol, which rules out malignancy; the rest of the cases of uncertain etiology are subject to evolution. The constitutional syndrome correlates well with good prognosis or medical functional processes. Although no clinical guidelines have been developed, score scales may help for the etiological assessment. Given the myriad of different causes of the constitutional syndrome, the treatment of this illness depends primarily on the etiology.

REFERENCES

1. Piquen A. Praxis médica. Madrid, España: Joaquín Ibarra; 1974.

2. De la Monte SM, Hutchins GM, Moore GW. Paraneoplastic syndromes and constitutional symptoms in prediction of metastatic behavior of small cell carcinoma of the lung. Am J Med. 1984;77(5):851-6.

3. Watanabe S, Bruera E. Anorexia and cachexia, asthenia, and lethargy. Hematol Oncol Clin North Am. 1996;10(1):189-206.

4. González-Macías J, Riancho JA. Síndrome de afectación general. En: García-Conde J, Merino J, González-Macías J, editores. Patología general: semiología clínica y fi siopatología. Madrid, España: Interamericana-McGraw-Hill; 1995.

5. McDonald N, Alexander HR, Bruera E. Cachexiaanorexia- asthenia. J Pain Symptom Manage. 1995; 10(2):151-5.

6. González-Barón M, Camps C, Carulla J, Cruz JJ, Lorenzo A, Montalar A, et al. Estudio de la astenia tumoral: constitución del grupo ASTHENOS. Rev Clin Esp. 2002;202(10):525-8.

7. Avellaneda-Fernández A, Pérez-Martín A, Izquierdo- Martínez M, Arruti-Bustillo M, Barbado-Hernández FJ, de la Cruz-Labrado J, et al. Chronic fatigue syndrome: aetiology, diagnosis and treatment. BMC Psychiatry. 2009;9(Suppl 1):S1.

8. Thompson MP, Morris LK. Unexplained weight loss in the ambulatory elderly. J Am Geriatric Soc. 1991;39(5):497-502.

9. Wenger NK, Schlant RC. Prevención de la aterosclerosis coronaria. En: Hurst JW, Logue RB, Rackley CE, Schlant RC, Sonnenblick EH, Wallace AG, et al., editores. El corazón. Sexta edición. Madrid, España: McGraw-Hill-Interamericana; 1988. p. 903-28.

10. Mckusick VA. El síndrome de Marfán. En: Mckusick VA, editor. Trastornos hereditarios del tejido conectivo. Barcelona, España: Labor; 1976. p. 71-240.

11. Tan BH, Fearon KC. Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care. 2008;11(4):400-7.

12. Milke-García P, Rivera-Flores R. Síndrome de anorexiacaquexia. Rev Gastroenterol Mex. 2010;75(Supl 2):205-7.

13. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr. 2006;83(4):735-43.

14. Braun TP, Marks DL. Pathophysiology and treatment of infl ammatory anorexia in chronic disease. J Cachexia Sarcopenia Muscle. 2010;1(2):135-45.

15. Sahyoun NR, Serdula MK, Galuska DA, Zhang XL, Pamuk ER. The epidemiology of recent involuntary weight loss in the United States population. J Nutr Health Aging. 2004;8(6):510-7.

16. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Defi nition and classifi cation of cancer cachexia: an international consensus Lancet Oncol. 2011;12(5):489-95.

17. Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P, et al. Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol. 2011;80(1):114-44.

18. Fearon KC. Cancer cachexia and fat-muscle physiology. N Engl J Med. 2011;365(6):565-7.

19. Alibhai SMH, Greenwood C, Payette H. An approach to the management of unintentional weight loss in elderly people. CMAJ. 2005;172(6):773-80.

20. Hernández-Hernández JL, Matorras-Galán P, Riancho- Moral JA, González-Macías J. Espectro etiológico del síndrome general solitario. Rev Clin Esp. 2002;202(7):367-74.

21. Bilbao-Garay J, Barba R, Losa-García JE, Martín H, García-de Casasola G, Castilla V, González-Anglada I, et al. Assessing clinical probability of organic disease in patients with involuntary weight loss: a simple score. Eur J Intern Med. 2002;13(4):240-5.

22. Lankisch PG, Gerzmann M, Gerzmann JF, Lehnick D. Unintentional weight loss: diagnosis and prognosis. The fi rst prospective follow-up study from a secondary referral centre. J Intern Med. 2001;249(1):41-6.

23. Hernández JL, Matorras P, Riancho JA, González- Macías J. Involuntary weight loss without specifi c symptoms: a clinical prediction score for malignant neoplasm. QJM. 2003;96(9):649-55.

24. Cózar-Santiago G, Molero-Santos P, Yurrita-Montesinos S, Civeira-Marín I. Protocolo diagnóstico del paciente depresivo. Medicine. 2011;10(84):5707-8.

25. Metalidis C, Knockaert DC, Bobbaers H, Vanderschueren S. Involuntary weight loss. Does a negative baseline evaluation provide adequate reassurance? Eur J Intern Med. 2008;19(5):345-9.

26. Calle EE, Thun MJ, Petrelli JM, Rodríguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341(15):1097-105.

27. Berrington-de González A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211-9.